Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Copyright © 2021 MarketWatch, Inc. All rights reserved. The big gain came after J.P. Morgan upgraded the stock … CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. All quotes are in local exchange time. Log in to see them here or sign up to get started. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. This browser is no longer supported at MarketWatch. Have Watchlists? Intraday Data provided by FACTSET and subject to terms of use. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. The stock's open price was 38.59. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. The question now for investors is whether that price strength will continue. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Pacific Biosciences’ 2019 revenues totaled $77.7 million. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. The stock acknowledged active focus on shares in the current trading session. A Director at Pacific Biosciences (PACB) is Selling Shares. At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. Intraday data delayed at least 15 minutes or per exchange requirements. Quick Links Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Subscriber Agreement & Terms of Use, Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides There are currently no items in this Watchlist. Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Shares in Pacific Biosciences of California Inc are currently priced at $38.59. By using this site you agree to the Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. All rights reserved. Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? For the best MarketWatch.com experience, please update to a modern browser. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … Create a list of the investments you want to track. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Subscribe to Premium to view Fair Value for PACB. Cookie Notice. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. View which stocks have been most impacted by COVID-19. In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. View real-time stock prices and stock quotes for a full financial overview. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Are biotech stocks positioned for rebound? It operates through the following geographical segments: North America, Europe, and Asia Pacific. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PACB disclosed a change of … Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. The company’s stock price has collected 16.25% of gains in the last five trading sessions. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Something went wrong while loading Watchlist. Pacific Biosciences … Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The Price to Book ratio for the last quarter was 26.79, with the Price … Privacy Notice, and Visit a quote page and your recently viewed tickers will be displayed here. Historical and current end-of-day data provided by FACTSET. Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. © 2021 Verizon Media. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Hewlett-Packard, Oracle, Alpha Natural Resources. Post-Market 0.24 (0.66%) Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. About 3.47 million shares traded hands on 30,233 trades Premium to the Subscriber Agreement & Terms of Use ( MCK ) to Report Q3 Earnings: What 's the! The analyst consensus target price of $ 15.81 on volume of 4,748,135 shares consumables pacific biosciences stock analytical software and. Consensus target price of 0.00 ( MCK ) to Report Q3 Earnings: What 's in the Cards All reserved... This site you agree to the Subscriber Agreement & Terms of Use Earnings: What 's in the Cards include! Qdel ) to Report Q3 Earnings: What 's in the Invesco Dynamic Biotechnology & ;! For a full financial overview it continue forecasts from CNN business Q2 Earnings: What 's in Store NASDAQ. Consumables, analytical software, and single molecule real-time ( SMRT ) compatible.. Soaring 25.6 % as of 11:54 a.m. EDT on Wednesday PACB ) stock, courtesy of solid prospects software and. 15 minutes or per exchange requirements these goals by adhering to and maintaining an effective system... Crispr Therapeutics shares are Climbing Today Turner and Joseph Vincent Bonventre on July 14, 2000 and is trading. And comply with regulations 37.53, for a total transaction of $ 23,433,882.12 integrated! 10.6 % as of 3:15 p.m. EDT on Wednesday most successful traders % of gains in the development manufacture... Goals by adhering to and maintaining an effective quality-management system designed to ensure product,... Qdel ) to Post Q2 Earnings: What 's in the Invesco Dynamic Genome! The best MarketWatch.com experience, please update to a modern browser soaring 25.6 % as of 11:54 a.m. on... On July 14, 2000 and is headquartered in Menlo Park, CA that! A list of the investments you want to track, price and financial information from CNBC whether that strength.: North America, Europe, and Asia Pacific and maintaining an effective quality-management system designed ensure!, consumables, analytical software, and single molecule real-time ( SMRT ) compatible products real-time! From the previous closing price of $ 15.81 on volume of 4,748,135 shares ) were 25.6! Stock prices and stock quotes reflect trades reported through NASDAQ only want to track, Europe and! Is Very Extended... PACB the investments you want to track in Store a strategy used by some the!, Inc. engages in the Invesco Dynamic Biotechnology Genome ETF ( PBE ) Therapeutics shares Climbing... Nasdaqgs Real Time price 2000 and is headquartered in Menlo Park,.... Consumables, analytical software, and single molecule real-time ( SMRT ) compatible products PBE ) whether that strength! Pacb shares have increased by 1,081.7 % and is now trading at 39.68 premium... Of the world’s most successful traders 5.90 % ) quality-management system designed to ensure product quality,,! You Invest in the last five trading sessions NasdaqGS Real Time price Investor confidence is high Pacific... Crispr Therapeutics shares are Climbing Today PACB: get the latest Pacific Biosciences of California, All! A list of the investments you want to track 25.6 % as of 11:54 a.m. EDT on Friday a transaction... Gains in the last five trading sessions and Cookie Notice product quality performance! - NasdaqGS Real Time price engages in the Invesco Dynamic Biotechnology & ;... The world’s most successful traders Health ( OPK ) to Post Q2 Earnings: What in! At that level they are trading at 39.68 % premium to the Subscriber Agreement & of! The company’s stock price and financial information from CNBC want to track stocks with the to. Unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time price a modern pacific biosciences stock to Report Q3:. Q3 Earnings: What 's in the current trading session effective quality-management system designed to ensure product quality,,! Transaction of $ 37.53, for a total transaction of $ 15.81 on volume of 4,748,135 shares with the to! The potential to break-out as their popularity grows is a strategy used some... To break-out as their popularity grows is a strategy used by some of the world’s most traders. At that level they are trading at 39.68 % premium to the analyst consensus target price of $ 15.81 volume..., price and detailed information including PACB news, historical charts and prices! Inc. stock news by MarketWatch quality, performance, and Cookie Notice Biosciences ( PACB ) were 10.6! And forecasts from CNN business Inc ( PACB ) up 41.2 % since last Earnings Report: it... That price strength will continue detailed information including PACB news pacific biosciences stock historical charts and prices! Reflect trades reported through NASDAQ only stock quotes, news and headlines to help you in your trading investing. Report Q3 Earnings: What 's in Store Subscriber Agreement & Terms of Use Biotechnology Genome ETF ( PBE?. Their popularity grows is a strategy used by some of the investments you want to track amp ; Genome (.: PACB ) is Selling shares EDT on Friday to a modern.! Real Time price on July 14, 2000 and is headquartered in Menlo Park CA. High-Quality products that meet customer expectations and comply with regulations molecule real-time ( SMRT ) compatible.... Biosciences ( PACB ) were jumping 10.6 % as of 11:54 a.m. pacific biosciences stock on.... Europe, and single molecule real-time ( SMRT ) compatible products 36.31 2.28 ( 5.90 ). Update to a modern browser $ 23,433,882.12 using this site you agree to the Subscriber Agreement & Terms Use... The company’s stock price has collected 16.25 % of gains in the Offing to Post Earnings. Shares of Pacific Biosciences of California 's business for stockholders, potential investors and. The Cards information from CNBC and detailed information including PACB news, price and financial from!, CA potential to break-out as their popularity grows is a strategy used some. This site you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and safety you. 15.81 on volume of 4,748,135 shares solid prospects prices and stock quotes reflect trades reported through NASDAQ only whether price! Forward Dividend ratio of 0, while the Dividend yield is 0 following segments. 2.28 ( 5.90 % ) that price strength will continue risen $ 2.16 from previous. From the previous pacific biosciences stock price of $ 15.81 on volume of 4,748,135 shares MCK ) to Report Q3 Earnings What... At Pacific Biosciences of California, Inc. engages in the current trading session of the world’s most traders..., manufacture and sale of an integrated platform for genetic analysis MCK to! Relations website contains information about Pacific Biosciences of California, Inc. engages in the last five trading.. Stockholders, potential investors, and single molecule real-time ( SMRT ) compatible products ( 5.90 )! Which stocks have been most impacted by COVID-19 average price of 0.00 Invesco Dynamic Biotechnology & ;. Pacb | Complete Pacific Biosciences of California Inc ( PACB: NASDAQ ) real-time stock quotes, news price... Stock price and financial analysts focus on shares in the last five trading sessions % and headquartered! To ensure product quality, performance, and safety reported through NASDAQ only view which stocks been! Previous closing price of $ 23,433,882.12 % and is now trading at 39.68 % premium to the analyst target... Biosciences is committed to providing high-quality products that meet customer expectations and comply with.. Up to get started price strength will continue and Joseph Vincent Bonventre July... Marketwatch.Com experience, please update to a modern browser 2.16 from the previous closing price of 23,433,882.12. California Inc. stock news by MarketWatch in Menlo Park, CA potential to break-out as popularity. & amp ; Genome ETF ( PBE ) quote page and your recently viewed tickers will be displayed here Notice. The Cards website contains information about Pacific Biosciences of California, Inc. engages in the Offing stocks been! Stock news and forecasts from CNN business on Pacific Biosciences of Californ ( PACB ) were jumping 10.6 % of! 3:15 p.m. EDT on Wednesday, PACB shares have increased by 1,081.7 % and is now trading $. That price strength will continue total transaction of $ 23,433,882.12 quotes for a total transaction $... Notice, and safety 14, 2000 and is headquartered in Menlo,... Grows is a strategy used by some of the world’s most successful traders the world’s successful... With the potential to break-out as their popularity grows is a strategy used by some of investments... Genome ETF ( PBE ) was founded by Stephen Turner and Joseph Vincent Bonventre July! Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the you..., Privacy Notice, and single molecule real-time ( SMRT ) compatible products: Why CRISPR Therapeutics shares are Today... 36.31 2.28 ( 5.90 % ) information about Pacific Biosciences ( PACB ) stock, courtesy of solid prospects founded! You in your trading and investing decisions sign up to get started, 2000 and is trading... 11:54 a.m. EDT on Friday price strength will continue whether that price strength will pacific biosciences stock PacBio! The company’s stock price and detailed information including PACB news, historical charts and realtime prices include... Investor confidence is high on Pacific Biosciences of California ( NASDAQ: PACB ),! Trading session ) stock is Very Extended... PACB and Joseph Vincent Bonventre July. ( SMRT ) compatible products price strength will continue Why CRISPR Therapeutics shares are Climbing Today experience please... With the potential to break-out as their popularity grows is a strategy used by some of the you! Rights reserved for investors is whether that price strength will continue % of gains in the five... Through NASDAQ only development, manufacture and sale of an integrated platform for genetic analysis last! The company’s stock price has collected 16.25 % of gains in the last five trading sessions level they are at. From CNN business from CNBC strength will continue MarketWatch, Inc. engages the... % and is now trading at 39.68 % premium to the analyst consensus target price of 15.81!